In October, due to demand from existing healthcare partners, CTS began testing blood donors for antibody to Babesia microti under an Investigational New Drug exemption as a release test.
CTS Tampa lab implements Dengue testing on behalf of a healthcare partner in an endemic area.
In April, CTS becomes the first blood donor testing organization in the US to implement Zika testing...
As a component of the CTS Business Continuity Plan, today all 6 labs began using the same laboratory...
In July, the six viral marker assay conversion at CTS Dallas, Phoenix and Tampa laboratories was ach...
By the end of 2017, CTS has secured three source plasma partners and continues to seek additional pa...
CTS embraces a company-wide operational excellence initiative designed to change the culture to enha...